Dual therapy stent

Dual Therapy Stent
Intervention

The Combo Dual Therapy Stent (OrbusNeich)

A dual therapy stent is a coronary artery stent that combines the technology of a bioengineered stent and a drug eluting stent to both accelerate endothelial coverage (healing of the vessel) and to block cell proliferation, thereby reducing the risk of restenosis.[1]

The Combo Dual Therapy Stent (OrbusNeich) is the only dual therapy stent available today. It combines the Genous endothelial progenitor cell capture technology with an antiproliferative, biodegradable sirolimus drug elution.[2] The Combo Stent has received CE Mark approval[3] in Europe and was shown to be as effective as a paclitaxel-eluting stent in controlling neointimal hyperplasia.[4]

References

  1. ↑ Dual-Therapy Stenting: The Next Step in the Evolution of Stent Design (Cardiology Today: Intervention)
  2. ↑ London, Susan (14 November 2011). "Bioengineered, Sirolimus-Eluting Stent Found ‘Safe,’ and ‘Effective.’" Cardiology News.
  3. ↑ First Dual-Therapy Stent Nets CE Mark (Cardiology Today’s Intervention)
  4. ↑ TCT: Combo Stent Comparable to Taxus (MedPage Today)


This article is issued from Wikipedia - version of the 3/7/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.